<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kairyte K</submitter><funding>The Doctoral Fund of Kaunas University of Technology</funding><pagination>970</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9415606</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(8)</volume><pubmed_abstract>The 1-(4-acetamidophenyl)-5-oxopyrrolidine carboxylic acid was applied for synthesizing derivatives bearing azole, diazole, and hydrazone moieties in the molecule. Modification of an acetamide fragment to the free amino group afforded compounds with two functional groups, which enabled to provide a series of 4-substituted-1-(4-substituted phenyl)pyrrolidine-2-ones. The resulted compounds &lt;b>2&lt;/b> and &lt;b>4&lt;/b>-&lt;b>22&lt;/b> were subjected to the in vitro anticancer and antimicrobial activity determination. The compounds &lt;b>18&lt;/b>-&lt;b>22&lt;/b> exerted the most potent anticancer activity against A549 cells. Furthermore, compound &lt;b>21&lt;/b> bearing 5-nitrothiophene substituents demonstrated promising and selective antimicrobial activity against multidrug-resistant &lt;i>Staphylococcus aureus&lt;/i> strains, including linezolid and tedizolid-resistant &lt;i>S. aureus&lt;/i>. These results demonstrate that 5-oxopyrolidine derivatives are attractive scaffolds for the further development of anticancer and antimicrobial compounds targeting multidrug-resistant Gram-positive pathogens.</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Synthesis and Biological Activity Characterization of Novel 5-Oxopyrrolidine Derivatives with Promising Anticancer and Antimicrobial Activity.</pubmed_title><pmcid>PMC9415606</pmcid><funding_grant_id>No. A-410, approved 26th of June, 2019</funding_grant_id><pubmed_authors>Sapijanskaite-Banevic B</pubmed_authors><pubmed_authors>Kairyte K</pubmed_authors><pubmed_authors>Grybaite B</pubmed_authors><pubmed_authors>Kavaliauskas P</pubmed_authors><pubmed_authors>Vaickelioniene R</pubmed_authors><pubmed_authors>Mickevicius V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and Biological Activity Characterization of Novel 5-Oxopyrrolidine Derivatives with Promising Anticancer and Antimicrobial Activity.</name><description>The 1-(4-acetamidophenyl)-5-oxopyrrolidine carboxylic acid was applied for synthesizing derivatives bearing azole, diazole, and hydrazone moieties in the molecule. Modification of an acetamide fragment to the free amino group afforded compounds with two functional groups, which enabled to provide a series of 4-substituted-1-(4-substituted phenyl)pyrrolidine-2-ones. The resulted compounds &lt;b>2&lt;/b> and &lt;b>4&lt;/b>-&lt;b>22&lt;/b> were subjected to the in vitro anticancer and antimicrobial activity determination. The compounds &lt;b>18&lt;/b>-&lt;b>22&lt;/b> exerted the most potent anticancer activity against A549 cells. Furthermore, compound &lt;b>21&lt;/b> bearing 5-nitrothiophene substituents demonstrated promising and selective antimicrobial activity against multidrug-resistant &lt;i>Staphylococcus aureus&lt;/i> strains, including linezolid and tedizolid-resistant &lt;i>S. aureus&lt;/i>. These results demonstrate that 5-oxopyrolidine derivatives are attractive scaffolds for the further development of anticancer and antimicrobial compounds targeting multidrug-resistant Gram-positive pathogens.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2024-11-15T17:11:49.168Z</modification><creation>2024-11-15T17:11:49.168Z</creation></dates><accession>S-EPMC9415606</accession><cross_references><pubmed>36015119</pubmed><doi>10.3390/ph15080970</doi></cross_references></HashMap>